Iridina Infezioni E Infiammazioni

Dexamethasone/Tobramycin, the active ingredient in Iridina Infezioni E Infiammazioni, is a corticosteroid/aminoglycoside antibiotic presented as an ophthalmic preparation for ocular use. It treats bacterial conjunctivitis, ocular inflammation, keratitis and post‑surgical eye inflammation in patients of all ages as directed by a healthcare professional.

GNH USA supplies Iridina Infezioni E Infiammazioni as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution through its experienced network of partners.

Iridina Infezioni E Infiammazioni combines a corticosteroid and an aminoglycoside antibiotic to address bacterial eye infections and inflammatory conditions. - Bacterial conjunctivitis: reduces bacterial load and alleviates redness, discharge and discomfort. - Ocular inflammation (e.g., uveitis, postoperative inflammation): suppresses inflammatory mediators to decrease swelling and pain. - Keratitis: provides antibacterial activity while controlling corneal inflammation. - Post‑surgical eye inflammation: prevents infection and controls postoperative swelling after ocular surgery.

The ocular formulation may cause local adverse reactions, ranging from mild to serious.

Common Side Effects: - Eye irritation or burning sensation. - Temporary blurred vision. - Increased intraocular pressure.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with eyelid swelling. - Corneal ulceration or perforation. - Vision loss.

When using Iridina Infezioni E Infiammazioni, consider the following precautions to ensure safe and effective therapy. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown; weigh potential risks and benefits. - Contact lens wearers: avoid using the drops while lenses are in place. - Pre‑existing glaucoma or ocular hypertension: monitor intraocular pressure closely. - Systemic corticosteroid therapy: may increase risk of systemic glucocorticoid effects. - Store at room temperature: keep in original container, protect from light and moisture.

Iridina Infezioni E Infiammazioni may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic corticosteroids: additive glucocorticoid effects may increase systemic exposure. - Other ophthalmic antibiotics: risk of antagonistic activity or toxicity. - Anticholinergic eye drops: may reduce the anti‑inflammatory efficacy. - Non‑steroidal anti‑inflammatory eye drops: increased risk of ocular irritation.

Moderate Interactions (Monitor Closely): - Topical beta‑blocker eye drops: may mask changes in intraocular pressure. - Antifungal eye preparations: possible reduced antifungal efficacy. - Systemic aminoglycosides: potential additive ototoxicity if systemic absorption occurs.